At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ADC Agree
Closed 08-04 16:00:00 EDT
76.32
-0.59
-0.77%
盘后76.32
+0.000.00%
19:34 EDT
High77.05Low75.42Vol2.23M
Open77.05D1 Closing76.91Amplitude2.12%
Mkt Cap9.49BTradable Cap9.32BTotal Shares124.38M
T/O170.34MT/O Rate1.83%Tradable Shares122.18M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Agree Realty Releases Transcript of Q2 2026 Earnings Call
Reuters  ·  05:53
Agree Realty Releases Transcript of Q2 2026 Earnings Call
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation
GlobeNewswire  ·  08-04 20:50
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation
Yomiuri: Japan, Mexico Agree to Expand Bilateral Cooperation on Economic Security, Energy
Dow Jones  ·  08-04 17:54
Yomiuri: Japan, Mexico Agree to Expand Bilateral Cooperation on Economic Security, Energy
Hong Kong Market Move: BIOCYTOGEN-B Surges Over 10% on Dual Antibody ADC Overseas Expansion, Preclinical CRO and Model Mouse Segments See Rising Momentum
Stock News  ·  08-04 15:06
Hong Kong Market Move: BIOCYTOGEN-B Surges Over 10% on Dual Antibody ADC Overseas Expansion, Preclinical CRO and Model Mouse Segments See Rising Momentum
ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal
Deep News  ·  08-04 10:02
ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal
Adlai Nortye Initiated at Buy as First-in-Class RASiCA ADC Enters Clinic; $20 Price Target Reiterated
TIPRANKS  ·  08-04 00:55
Adlai Nortye Initiated at Buy as First-in-Class RASiCA ADC Enters Clinic; $20 Price Target Reiterated
BofA Securities Adjusts Agree Realty Price Target to $93 From $92
MT Newswires Live  ·  08-03 19:38
BofA Securities Adjusts Agree Realty Price Target to $93 From $92
How Investors Are Reacting To Agree Realty (ADC) Earnings Growth Outpacing Diluted EPS Gains
Simply Wall St.  ·  08-03 18:17
How Investors Are Reacting To Agree Realty (ADC) Earnings Growth Outpacing Diluted EPS Gains
SBP Group's Third Breakthrough Therapy Designation for TQB2102 Strengthens Its Position in HER2-Targeted Cancer Treatments
Stock News  ·  08-03 16:40
SBP Group's Third Breakthrough Therapy Designation for TQB2102 Strengthens Its Position in HER2-Targeted Cancer Treatments
Hong Kong Stock Moves: Biocytogen-B Surges Over 8% Afternoon Following Whitehawk Deal, Five Bispecific ADC Candidates Going Global
Stock News  ·  08-03 14:32
Hong Kong Stock Moves: Biocytogen-B Surges Over 8% Afternoon Following Whitehawk Deal, Five Bispecific ADC Candidates Going Global
Can Agree Realty (ADC) Justify Its Valuation Following Raised Guidance And A Dividend Increase?
Simply Wall St.  ·  08-02 15:19
Can Agree Realty (ADC) Justify Its Valuation Following Raised Guidance And A Dividend Increase?
How Much Should an AI Agent Cost? no One Can Agree - and It's Creating Chaos.
Dow Jones  ·  08-01
How Much Should an AI Agent Cost? no One Can Agree - and It's Creating Chaos.
Analysts Offer Insights on Real Estate Companies: Safehold (SAFE), Agree Realty (ADC) and Mid-America Apartment (MAA)
TIPRANKS  ·  07-31
Analysts Offer Insights on Real Estate Companies: Safehold (SAFE), Agree Realty (ADC) and Mid-America Apartment (MAA)
Federal Realty Q2 Core FFO Per Share Rises on Record Leasing Activity
Reuters  ·  07-31
Federal Realty Q2 Core FFO Per Share Rises on Record Leasing Activity
Agree Realty price target raised to $83 from $82 at Baird
TIPRANKS  ·  07-31
Agree Realty price target raised to $83 from $82 at Baird
Agree Realty Corp Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  07-31
Agree Realty Corp Reports Results for the Quarter Ended June 30 - Earnings Summary
Analyst Backs Crescent Biopharma With Buy Rating on Advancing ADC Pipeline and Strong Cash Runway
TIPRANKS  ·  07-31
Analyst Backs Crescent Biopharma With Buy Rating on Advancing ADC Pipeline and Strong Cash Runway
GUIDANCE: (ADC) Agree Realty Now Expects 2026 Adjusted FFO Per Share Range $4.57-$4.59, vs. FactSet Est of $4.57
MT Newswires Live  ·  07-31
GUIDANCE: (ADC) Agree Realty Now Expects 2026 Adjusted FFO Per Share Range $4.57-$4.59, vs. FactSet Est of $4.57
Agree Realty Q2 FY26 Net Income Rises 11.5% to $52.8 Million
Reuters  ·  07-31
Agree Realty Q2 FY26 Net Income Rises 11.5% to $52.8 Million
Agree Realty reports Q2 AFFO $1.14, consensus $1.13
TIPRANKS  ·  07-31
Agree Realty reports Q2 AFFO $1.14, consensus $1.13

Introduction

Company Name.
Agree
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Agree Realty Corporation (the “Company”), a Maryland corporation, is a fully integrated real estate investment trust (“REIT”) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (“GLA”) of approximately 44.9 million square feet.
Issue price:
--